Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) have received a consensus recommendation of “Buy” from the twenty-three analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $87.00.

WBA has been the subject of several research analyst reports. Jefferies Group LLC restated a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Wednesday, September 20th. Needham & Company LLC set a $94.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Monday, July 17th. Credit Suisse Group restated a “buy” rating and set a $97.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, July 13th. Loop Capital initiated coverage on Walgreens Boots Alliance in a research note on Thursday, August 24th. They set a “buy” rating and a $95.00 price target for the company. Finally, UBS AG restated a “buy” rating and set a $96.00 price target (down from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd.

ILLEGAL ACTIVITY WARNING: “Analysts Set Walgreens Boots Alliance, Inc. (WBA) Target Price at $87.00” was first published by Watch List News and is owned by of Watch List News. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.watchlistnews.com/analysts-set-walgreens-boots-alliance-inc-wba-target-price-at-87-00/1691313.html.

Shares of Walgreens Boots Alliance (WBA) traded up $0.64 during trading hours on Monday, reaching $69.54. The company’s stock had a trading volume of 7,893,328 shares, compared to its average volume of 9,918,977. The firm has a market capitalization of $68,568.57, a price-to-earnings ratio of 13.32, a PEG ratio of 1.21 and a beta of 1.20. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. Walgreens Boots Alliance has a 12 month low of $63.82 and a 12 month high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.21 by $0.10. The company had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm’s revenue was up 5.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.07 earnings per share. research analysts predict that Walgreens Boots Alliance will post 5.55 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.

Walgreens Boots Alliance declared that its Board of Directors has approved a share repurchase plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Shares repurchase plans are usually a sign that the company’s board believes its stock is undervalued.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The shares were purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. Corporate insiders own 13.50% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its holdings in shares of Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock worth $5,480,577,000 after purchasing an additional 1,926,108 shares during the last quarter. State Street Corp lifted its holdings in shares of Walgreens Boots Alliance by 1.8% in the 1st quarter. State Street Corp now owns 37,612,843 shares of the pharmacy operator’s stock worth $3,123,757,000 after purchasing an additional 677,743 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of Walgreens Boots Alliance by 5.9% in the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock worth $2,727,932,000 after purchasing an additional 1,824,300 shares during the last quarter. Franklin Resources Inc. lifted its holdings in shares of Walgreens Boots Alliance by 24.7% in the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock worth $1,448,939,000 after purchasing an additional 3,662,302 shares during the last quarter. Finally, Nordea Investment Management AB lifted its holdings in shares of Walgreens Boots Alliance by 1.0% in the 3rd quarter. Nordea Investment Management AB now owns 10,182,388 shares of the pharmacy operator’s stock worth $786,284,000 after purchasing an additional 96,552 shares during the last quarter. 63.79% of the stock is currently owned by institutional investors.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.